Dopamine alters functional gradients in Parkinson’s disease
Imaging Neuroscience · 06.05.2025 · 3
DOI: 10.1162/imag_a_00564 ↗Kurz gefasst
Fachartikel in der Zeitschrift Imaging Neuroscience, online erschienen am 06.05.2025. Verfasst von Isabella F Orlando und 7 weiteren Autor:innen. Beteiligte Einrichtung: Brain and Mind Centre and School of Medical Sciences, Faculty of Medicine and Health, University of Sydney, Sydney, Australia. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 120 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council.
Abstract (Originalsprache)
Neuromodulators regulate large-scale brain network topology to support adaptive behaviour. Disease models offer a unique window into how neuromodulatory systems impact large-scale brain network organisation. Here, we take advantage of Parkinson’s disease—with its profound dopaminergic loss and pro-dopaminergic treatment strategies—to inform how dopamine may influence large-scale brain organisation. In 27 people with Parkinson’s disease, resting-state scans were obtained on their regular dopamine medication and following overnight withdrawal of medication. Nineteen matched controls provided normative data. Gradients of brain organisation were examined using dimensionality reduction techniques. For single gradients, when individuals were on their dopamine medication, we observed a shift in higher-order networks towards somatomotor anchors. When interrogated in the multi-dimensional gradient space, we found that dopamine medication enhanced separation between functionally discrete sensory and higher-order networks. This increase in dispersion was dependent on an individual’s dopamine dose level, and increased dispersion was more apparent in regions enriched with dopamine receptor (DRD2) gene expression. Together, these findings substantiate a role for dopamine in modulating large-scale functional brain organisation. Our findings further confirm that medication targeting the dopamine system may achieve its benefit by restoring aspects of network topology, and suggest new hypotheses about how dopamine medication is influencing large-scale functional brain organisation in Parkinson’s disease.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Brain and Mind Centre and School of Medical Sciences, Faculty of Medicine and Health, University of Sydney, Sydney, Australia.
- Latin American Brain Health Institute (BrainLat), Universidad Adolfo Ibáñez, Santiago, Chile.
- Macquarie University Centre for Parkinson's Disease Research and Macquarie Medical School, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, New South Wales, Australia.
- Centre for Complex Systems, School of Physics, University of Sydney, Sydney, Australia.
ORCID-Profile: Isabella F Orlando, Claire O'Callaghan
Förderung
- National Health and Medical Research Council
Zitieren
APA
Orlando, I. F., Tan, J. B., Taylor, N. L., Medel, V., Wainstein, G., Lewis, S. J. G., Shine, J. M., & O'Callaghan, C. (2025). Dopamine alters functional gradients in Parkinson’s disease. Imaging Neuroscience, 3. https://doi.org/10.1162/imag_a_00564
Vancouver
Orlando IF, Tan JB, Taylor NL, Medel V, Wainstein G, Lewis SJG, et al. Dopamine alters functional gradients in Parkinson’s disease. Imaging Neuroscience. 2025;3. doi:10.1162/imag_a_00564
BibTeX
@article{Orlando2025,
author = {Orlando, Isabella F and Tan, Joshua B and Taylor, Natasha L and Medel, Vicente and Wainstein, Gabriel and Lewis, Simon J G and Shine, James M and O'Callaghan, Claire},
title = {Dopamine alters functional gradients in Parkinson’s disease},
journal = {Imaging Neuroscience},
year = {2025},
volume = {3},
doi = {10.1162/imag_a_00564}
}
EUVIMED